[1] Culshaw RV, Ruan S (2000) A delay-differential equation model of HIV infection of CD4+T-Cells. Math Biosci 165 (1): 27-39.

[2] Boshoff C, Weiss R (2002) AIDS-related malignancies. Nat Rev Cancer 2 (5):373-382.

[3] Hashmi MU, Suleman M, Zaidi SMJ, Habib M (2014) Modeling the tumor-immune interaction cultured with chemotherapy and cytokine interleukin il-2 under the influence of immunodeficiency viruses. Am-Eurasian J Toxicol Sci 6(4): 74-82.

[4] Rihan A, Abdel Rahman DH (2013) Delay differential model for tumor-immune dynamics with HIV infection of CD4+ T-cells. International Journal of Computer Mathematics 90 (3): 594-614.

[5] Aogo R, Nyabadza F (2017) Modelling the dynamics of HIV-related non-Hodgkin lymphomas in the presence of HIV treatment and chemotherapy. Math Method Appl Sci        1-22.

[6] Nazari M, Ghaffari A, Arab F (2015) Finite duration treatment of cancer by using vaccine therapy and optimal chemotherapy: State-dependent riccati equation control and extended kalman filteR. J Biol Syst 23(1).

[7] Ghaffari A, Nazari M, Arab F (2015) Suboptimal mixed vaccine and chemotherapy in finite duration cancer treatment: state-dependent Riccati equation control. J Braz Soc Mech Sci 37(1): 45-56.

[8] Ruff R, Puetter A, Levy LS (2007) Growth regulation of simian and human AIDS-related non-hodgkin's lymphoma cell lines by TGF-beta1and IL-6. BMC Cancer 7(1): 7-35.

[9] Nazari M, Ghaffari A (2015) The effect of finite duration inputs on the dynamics of a system: Proposing a new approach for cancer treatment. Int J Biomath 8(3): 1-19.

[10]  Ghaffari A, Nazari M, Khazaee M, Bahmaei B (2014) Changing the dynamics of a system by using finite duration inputs: Application to cancer modeling and treatment. Journal of Solid and Fluid Mechanics 4(1): 79-91.

[11] De Pillis LG, Gu W, Radunskaya AE (2006) Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations. J Theor Biol 238: 841-862.

[12] De Pillis LG, Gu W, Radunskaya AE (2006) Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations. J Theor Biol 238(4): 841-862.

[13] Ghaffari A, Khazaee M (2012) Cancer dynamics for identical twin brothers. Theor Biol Med Model 9(1):4.

[14] Pinho STR, Freedman HI, Nani F (2002) Chemotherapy model for the treatment of cancer with metastasis. Math Comput Model 36: 773-803.

[15] Cimen T (2010) Systematic and effective design of nonlinear feedback controllers via the state-dependent Riccati equation (SDRE) method. Annu Rev Control 34: 32-51.

[16] Wu X, Liu Q, Zhang K, Cheng M, Xin X (2018) Optimal switching control for drug therapy process in cancer chemotherapy. Eur J Control 42: 49-58

[17] Chen T, Kirkby NF, Jena R (2012) Optimal dosing of cancer chemotherapy using model predictive control and moving horizon state/parameter estimation. Comput Meth Prog Bio 108(3): 337-1340.

[18] Babaei N, Salamci M (2017) Controller design for personalized drug administration in cancer therapy: Successive approximation approach. Optim Contr Appl Met 1-38.

[19] Rihan FA, Lakshmanan S, Maurer H (2019) Optimal control of tumour-immune model with time-delay and immuno-chemotherapy. Appl Math Comput 353: 147-165.

[20] Ghaffari A, Bahmaei B, Nazari M (2016) Amixed radiotherapy and chemotherapy model for treatment of cancer withmetastasis. Math Method Appl Sci 39(15): 4603-4617.

[21] Batmani Y, Khaloozadeh H (2012) Optimal chemotherapy in cancer treatment: State dependent Riccati equation control and extended Kalman filter. Optim Contr Appl Met 34: 562-577.

[22] Babaei N, Salamci MU (2019) Mixed therapy in cancer treatment for personalized drug administration using model reference adaptive control. Eur J Control. In press.